The graph displaying the distribution of IL-6 concentrations among groups indicates a peak in IL-6 concentrations in patients with stage IIB (me = 44.14 pg/mL), IIIA (me = 47.36 pg/mL), and IIIB (me = 37.00 pg/mL) lung cancer. The gene discussed is IL6; the disease is lung carcinoma.